Progression of osteoporosis in patients with COPD: A 3-year follow up study

Respiratory Medicine

Volumn 106, Issue 6, 2012, Pages 861-870

  Graat Verboom, Lidwien ^a,b   Smeenk, Frank W J M ^a   Van Den Borne, Ben E E M ^a   Spruit, Martijn A ^c   Jansen, Frits H ^a   Van Enschot, Joris W T ^a   Wouters, Emiel F M ^b,c  

^a CATHARINA HOSPITAL   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CIRO+   (Netherlands)

Author keywords

Bone mineral density; Chronic Obstructive Pulmonary Disease; Co morbidities; Osteoporosis; Vertebral fractures

Indexed keywords

ADULT; AGED; ARTICLE; BODY COMPOSITION; BONE DENSITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GREATER TROCHANTER; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VERTEBRA FRACTURE; VITAMIN D DEFICIENCY; WALKING;

AGED; AGED, 80 AND OVER; BONE DENSITY; DISEASE PROGRESSION; FEMALE; FEMUR; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SPINAL FRACTURES; VITAMIN D DEFICIENCY;

EID: 84859805050     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.12.020     Document Type: Article

References (49)

1. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176(6):532-55. (Pubitemid 47403272)
2. Spruit MA, Pennings HJ, Janssen PP, et al. Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade. Respir Med 2007;101(12):2454-63. (Pubitemid 47618382)
3. Spruit MA, Watkins ML, Edwards LD, et al. Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med 2010;104(6):849-57.
4. Graat-Verboom L, Wouters EF, Smeenk FW, et al. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J 2009;34(1):209-18.
5. Kjensli A, Falch JA, Ryg M, et al. High prevalence of vertebral deformities in COPD patients: relation to disease severity. Eur Respir J 2009;33(5):1018-24.
6. WHO Scientific Group on the Prevention and Management of Osteoporosis. Prevention and management of osteoporosis: report of a WHO scientific group; 2007.
7. Graat-Verboom L, Spruit MA, van den Borne BE, et al. Whole-body versus local DXA-scan for the diagnosis of osteoporosis in COPD patients. J Osteoporos 2010;2010:640878.
8. Graat-Verboom L, van den Borne BE, Smeenk FW, et al. Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures. J Bone Miner Res 2011;26(3):561-8.
9. Jorgensen NR, Schwarz P, Holme I, et al. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. RespirMed 2007;101(1):177-85. (Pubitemid 44835231)
10. Scanlon PD, Connett JE, Wise RA, et al. Loss of bone density with inhaled triamcinolone in lung health study II. Am J Respir Crit Care Med 2004;170(12):1302-9. (Pubitemid 39657194)
11. Mineo TC, Ambrogi V, Mineo D, et al. Bone mineral density improvement after lung volume reduction surgery for severe emphysema. Chest 2005;127(6):1960-6.
12. Ferguson GT, Calverley PM, Anderson JA, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the towards a revolution in COPD health study. Chest 2009;136(6):1456-65.
13. Heijckmann AC, Drent M, Dumitrescu B, et al. Progressive vertebral deformities despite unchanged bone mineral density in patients with sarcoidosis: a 4-year follow-up study. Osteoporos Int 2008;19(6):839-47.
14. American Thoracic Society and European Respiratory Society. COPD guidelines. Standards for the diagnosis and treatment; 2004.
15. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47(11):1245-51. (Pubitemid 24361532)
16. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111-7.
17. Genant HK, Wu CY, van KC, et al. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993;8(9):1137-48. (Pubitemid 23261108)
18. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357(3):266-81.
19. Norman AW, Bouillon R, Whiting SJ, et al. 13th Workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 2007;103(3-5):204-5. (Pubitemid 46420528)
20. Hofbauer LC, Schoppet M. Clinical implications of the osteoprotegerin/ RANKL/RANK system for bone and vascular diseases. JAMA 2004;292(4):490-5. (Pubitemid 38988958)
21. Walsh NC, Gravallese EM. Bone remodeling in rheumatic disease: a question of balance. Immunol Rev 2010;233(1):301-12.
22. Viguet-Carrin S, Garnero P, Delmas PD. The role of collagen in bone strength. Osteoporos Int 2006;17(3):319-36.
23. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33(5):1165-85.
24. Agusti AG. COPD, a multicomponent disease: implications for management. Respir Med 2005;99(6):670-82. (Pubitemid 40631293)
25. Franciosi LG, Page CP, Celli BR, et al. Markers of disease severity in chronic obstructive pulmonary disease. Pulm Pharmacol Ther 2006;19(3):189-99.
26. Particelli F, Mecozzi L, Beraudi A, et al. A comparison between micro-CT and histology for the evaluation of cortical bone: effect of polymethylmethacrylate embedding on structural parameters. J Microsc 2011.
27. Szulc P, Debiesse E, Boutroy S, et al. Poor trabecular microarchitecture in male current smokers: the cross-sectional STRAMBO study. Calcif Tissue Int 2011;89(4):303-11.
28. Leech JA, Dulberg C, Kellie S, et al. Relationship of lung function to severity of osteoporosis in women. Am Rev Respir Dis 1990;141(1):68-71. (Pubitemid 20023384)
29. Yang HL, Zhao L, Liu J, et al. Changes of pulmonary function for patients with osteoporotic vertebral compression fractures after kyphoplasty. J Spinal Disord Tech 2007;20(3):221-5. (Pubitemid 46701414)
30. Nuti R, Siviero P, Maggi S, et al. Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study. Osteoporos Int 2008;20(6):989-98.
31. Papaioannou A, Parkinson W, Ferko N, et al. Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporos Int 2003;14(11):913-7. (Pubitemid 38009531)
32. Kuchuk NO, van Schoor NM, Pluijm SM, et al. Vitamin D status, parathyroid function, bone turnover and bone mineral density in postmenopausal women with osteoporosis in global perspective. J Bone Miner Res 2008.
33. Andersson I, Gronberg A, Slinde F, et al. Vitamin and mineral status in elderly patients with chronic obstructive pulmonary disease. Clin Respir J 2007;1(1):23-9.
34. de BJ, Romieu I, Anto JM, et al. Dietary habits of firstly admitted Spanish COPD patients. Respir Med 2009;103(12):1904-10.
35. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest 2005;128(6):3792-8. (Pubitemid 43062638)
36. Forli L, Halse J, Haug E, et al. Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease. J Intern Med 2004;256(1):56-62. (Pubitemid 38813620)
37. Janssens W, Lehouck A, Carremans C, et al. Vitamin D beyond bones in COPD: time to act. Am J Respir Crit Care Med 2009;179(8):630-6.
38. Hancock DB, Eijgelsheim M, Wilk JB, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 2010;42(1):45-52.
39. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, et al. New sequence variants associated with bone mineral density. Nat Genet 2009;41(1):15-7.
40. Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010;65(3):215-20.
41. Watz H, Waschki B, Boehme C, et al. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 2008;177(7):743-51. (Pubitemid 351490561)
42. Watz H, Waschki B, Meyer T, et al. Physical activity in patients with COPD. Eur Respir J 2009;33(2):262-72.
43. Langer D, Gosselink R, Pitta F, et al. Physical activity in daily life 1 year after lung transplantation. J Heart Lung Transplant 2009;28(6):572-8.
44. Chapurlat RD, Duboeuf F, Marion-Audibert HO, et al. Effectiveness of instant vertebral assessment to detect prevalent vertebral fracture. Osteoporos Int 2006;17(8):1189-95.
45. Pitta F, Troosters T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171(9):972-7. (Pubitemid 40616945)
46. Boonen S, Adachi JD, Man Z, et al. Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk. J Clin Endocrinol Metab 2011.
47. Bonjoch A, Figueras M, Estany C, et al. High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study. AIDS 2010;24(18):2827-33.
48. Hoes JN, Jacobs JW, Hulsmans HM, et al. High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the alendronate or alfacalcidol in glucocorticoid-induced osteoporosis-trial. Clin Exp Rheumatol 2010;28(3):354-9.
49. Lehouck A, Boonen S, Decramer M, et al. COPD, bone metabolism, and osteoporosis. Chest 2011;139(3):648-57.